{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:49:19Z","timestamp":1774338559182,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tmaid.2023.102565","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T13:19:29Z","timestamp":1678972769000},"page":"102565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021"],"prefix":"10.1016","volume":"53","author":[{"given":"Javier","family":"Silva-Valencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy","family":"Soto-Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Escobar-Agreda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Fernandez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Moscoso-Porras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-8807","authenticated-orcid":false,"given":"Lely","family":"Solari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy","family":"Mayta-Trist\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2023.102565_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(21)01551-8","article-title":"COVID-19 in Latin America\u2014emergency and opportunity","volume":"398","author":"Lancet","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2023.102565_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tmaid.2023.102565_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102565_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: A Randomized Clinical Trial","volume":"326","author":"Al Kaabi","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.tmaid.2023.102565_bib7","unstructured":"Argentina, Ministerio de Salud. Estudio efectividad de campa\u00f1a nacional de vacunaci\u00f3n en reducci\u00f3n de la mortalidad por COVID-19 en personas de 60 a\u00f1os y mayores. Argentina. vol. 17."},{"key":"10.1016\/j.tmaid.2023.102565_bib8","series-title":"Neutralizing activity of BBIBP-CorV vaccine-elicited sera against multiple SARS-CoV-2 variants of concern","author":"Zhang","year":"2021"},{"key":"10.1016\/j.tmaid.2023.102565_bib9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1056\/NEJMc2103022","article-title":"Susceptibility of circulating SARS-CoV-2 variants to neutralization","volume":"384","author":"Wang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2023.102565_bib10","doi-asserted-by":"crossref","first-page":"105086","DOI":"10.1016\/j.micpath.2021.105086","article-title":"Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain","volume":"158","author":"Jahromi","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tmaid.2023.102565_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijid.2021.06.040","article-title":"Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?","volume":"110","author":"Alhinai","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2023.102565_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69336","article-title":"Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset","volume":"10","author":"Karlinsky","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.tmaid.2023.102565_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2021.07.022","article-title":"High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!","volume":"109","author":"N\u00fa\u00f1ez-Zapata","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2023.102565_bib14","first-page":"119","article-title":"Riesgo y muerte de los m\u00e9dicos a 100 d\u00edas del estado de emergencia por el COVID-19 en Per\u00fa","volume":"37","author":"Gal\u00e1n-Rodas","year":"2020","journal-title":"Acta M\u00e9d Peru"},{"key":"10.1016\/j.tmaid.2023.102565_bib15","doi-asserted-by":"crossref","DOI":"10.15381\/anales.v82i2.20766","article-title":"Supervivencia de los trabajadores de salud infectados por SARS-CoV-2 en el contexto de la vacunaci\u00f3n contra la COVID-19 en el Per\u00fa","volume":"82","author":"Escobar-Agreda","year":"2021","journal-title":"An Fac Med"},{"key":"10.1016\/j.tmaid.2023.102565_bib16","doi-asserted-by":"crossref","unstructured":"Padilla-Rojas C, Jimenez-Vasquez V, Hurtado V, et al. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern. J Med Virol; n\/a. DOI:10.1002\/jmv.27261.","DOI":"10.1002\/jmv.27261"},{"key":"10.1016\/j.tmaid.2023.102565_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.17843\/rpmesp.2015.322.1636","article-title":"Garro Nu\u00f1ez GM. Sistema de informaci\u00f3n de la red nacional de laboratorios de salud p\u00fablica en el Per\u00fa (Netlab)","volume":"32","author":"Vargas-Herrera","year":"2015","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"10.1016\/j.tmaid.2023.102565_bib19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.dsx.2020.06.064","article-title":"Coronavirus disease (COVID-19): a systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events","volume":"14","author":"Nandy","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.tmaid.2023.102565_bib20","series-title":"Flexible imputation of missing data","author":"Van Buuren","year":"2018"},{"key":"10.1016\/j.tmaid.2023.102565_bib22","doi-asserted-by":"crossref","unstructured":"Baj A, Novazzi F, Ferrante FD, et al. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. J. Med. Virol.; n\/a. DOI:10.1002\/jmv.27235.","DOI":"10.1002\/jmv.27235"},{"key":"10.1016\/j.tmaid.2023.102565_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.08.067","article-title":"SARS-CoV-2 infections in 165 countries over time","author":"Louca","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2023.102565_bib24","first-page":"M20","article-title":"Risk compensation and COVID-19 vaccines","author":"Trogen","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2023.102565_bib25","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2023.102565_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/M20-7866","article-title":"Speed versus efficacy: quantifying potential tradeoffs in COVID-19 vaccine deployment","volume":"174","author":"Paltiel","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2023.102565_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.17843\/rpmesp.2018.353.3913","article-title":"Resultados preliminares del fortalecimiento del sistema inform\u00e1tico nacional de defunciones","volume":"35","author":"Vargas-Herrera","year":"2018","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"10.1016\/j.tmaid.2023.102565_bib29","doi-asserted-by":"crossref","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ."}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789392300025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789392300025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:08:50Z","timestamp":1761487730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147789392300025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"alternative-id":["S147789392300025X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102565","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102565"}}